Morgan Stanley I Bio, Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $160.0 $62,509 - $43.5 Million	-271,779 Reduced 81.53%	61,575 $11,000
Q2 2022 Oct 27, 2022	BUY	$0.23 - $0.46 $41,768 - $83,536	181,600 Added 119.67%	333,354 $88,000
Q2 2022 Aug 15, 2022	BUY	$0.23 - $0.46 $41,768 - $83,536	181,600 Added 119.67%	333,354 $88,000
Q1 2022 Oct 27, 2022	SELL	$0.3 - $0.61 $54,480 - $110,776	-181,600 Reduced 54.48%	151,754 $64,000
Q1 2022 May 13, 2022	SELL	$0.3 - $0.61 $2,329 - $4,736	-7,764 Reduced 4.87%	151,754 $64,000
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $16,063 - $30,375	29,207 Added 22.41%	159,518 $86,000
Q3 2021 Nov 15, 2021	BUY	$1.06 - $1.52 $138,129 - $198,072	130,311 New	130,311 $138,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.1M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.